A Phase II Study of Perioperative S-1 Combined With Weekly Docetaxel in Patients With Locally Advanced Gastric Carcinoma: Clinical Outcomes and Clinicopathological and Pharmacogenetic Predictors for Survival
Gastric Cancer - Germany
doi 10.1007/s10120-015-0490-3
Full Text
Open PDFAbstract
Available in full text
Date
April 8, 2015
Authors
Publisher
Springer Science and Business Media LLC